This $626,609 project grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to evaluate a community-to-facility integrated strategy for implementing the World Health Organization's HEARTS-D module to improve diabetes care and outcomes in urban Bangladesh. The key activities involve: 1) Developing and optimizing the implementation strategy through mixed methods assessments, implementation mapping, and iterative...
This Project Grant award for $1,206,248 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to test the effectiveness of the "Sumadhur" intervention to reduce anemia and improve micronutrient status among young, preconception women in Nepal. The key products and services to be delivered through this 5-year award include: Conducting a 2-arm cluster randomized controlled...
This Project Grant award of $498,129.23 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports a research initiative by Dr. Agarwal at The Washington University to evaluate the implementation of a heart failure polypill strategy in India. The key products and services to be delivered under this award include: 1) Formative mixed methods research, including a heart failure treatment consensus meeting and focus groups, to guide development of the...
This federal Project Grant award of $116,748.00, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to enhance the recipient's capability as a leader in patient-oriented cardiovascular research and mentorship at Washington University. The key products and services to be delivered under this grant include: 1) Conducting new advanced implementation research using the NHLBI-funded Hypertension Treatment in Nigeria...
This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $989,908 to the University of Nevada, Las Vegas (UNLV) to conduct research aimed at improving the efficacy of cell-based cardiac repair. The key objectives are to: 1) Examine whether recombinant WNT11 can render mesenchymal stem cells (MSCs) more resistant to apoptosis and washout, thereby improving their retention following transplantation into the infarcted...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will fund the implementation and pilot-testing of an integrated sickle-cell screening and violence prevention program in antenatal care settings in India. The $167,560 award to the Trustees of Boston University, Massachusetts will be used to: 1) conduct formative research to inform the adaptation of the Jamii Bora intervention, 2) adapt the...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $100,558 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to Stellenbosch University in South Africa. The grant, effective September 11, 2024 through August 31, 2029, will fund a series of prospective, multimodal cardiovascular research studies. The research aims to explore the underlying mechanisms of cardiovascular disease (CVD) in people living with HIV, characterize the impact of antiretroviral...
This Project Grant award of $893,525 from the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program will fund a 40-month multi-component intervention study to protect lung health in Nepal. The study aims to test the implementation and effectiveness of a tailored evidence-based intervention targeting environmental risk factors, infectious risks, and physical activity to reduce the incidence and severity of chronic respiratory diseases....
This Project Grant award from the National Institutes of Health's Trans-NIH Research Support program (CFDA 93.310) is for $940,798 and will be conducted from Aug 2024 to Apr 2029. The project aims to create a stepped care model to help under-resourced cardiovascular disease patients maintain improvements in health behaviors, such as weight management, physical activity, and medication adherence, after completing cardiac rehabilitation. The study will utilize a Sequential, Multiple Assignment,...
This Project Grant award of $162,820 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), supports research to develop a community-clinical linkage model to facilitate referral of people living with HIV (PLWH) and comorbid hypertension to primary healthcare centers in Akwa Ibom, Nigeria. The research aims are to: 1) identify barriers and facilitators to this model, 2) co-develop a culturally-tailored,...